Life sciences software & AI news

Showing 1000+ results

A qubit device on a lab bench in a dimly lit laboratory

Sep 8, 2026

How GPT-5.6 Sol helps run quantum computing experiments

Recent advancements in AI are significantly enhancing the efficiency of quantum computing experiments, as demonstrated by Beatriz Yankelevich's innovative use of GPT-5.6 Sol in her research at MIT.Quantum computing leverages the unique properties of quantum mechanics to process information through quantum bits, or qubits. The preparation and execution of experiments involving qubits can be lengthy and complex, often requiring extensive preliminary measurements. Yankelevich utilized GPT-5.6 Sol,

A nurse's hand holding a patient chart in a dimly lit hospital room.

Sep 8, 2026

Measuring AI's value for nurses, beyond faster charting

The integration of AI in nursing documentation raises critical questions about its impact on patient care and efficiency.As artificial intelligence (AI) tools increasingly enter nursing workflows, the primary concern is whether they genuinely enhance bedside care or merely shift administrative burdens. Tracy Breece, a nursing informatics expert, emphasizes that the most effective AI solutions are those designed specifically for nursing practices rather than adapted from other clinical workflows.

A minimalist representation of a small molecule structure in a dark palette.

Sep 8, 2026

Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics

Schrödinger has unveiled Tectora Therapeutics, a new biotech entity focused on immunology and inflammation, backed by a $55 million Series A funding round.Tectora Therapeutics emerges from Schrödinger's strategic initiative to expand its footprint in drug development, particularly in immune diseases. By contributing two early-stage small molecule programs, Schrödinger not only gains an equity position in Tectora but also stands to benefit from potential future milestones and royalties. This coll

Sep 8, 2026

Press release

Endeavor BioMedicines Presents New Quantitative Imaging Data from Analysis of Phase 2a Clinical Trial Evaluating Taladegib (ENV-101) in Patients with Idiopathic Pulmonary Fibrosis

Findings presented at the European Respiratory Society Congress 2026 corroborate previous findings and provide continued clinical evidence supporting taladegibSAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today presented a quantitative imaging post hoc analysis from its Phase 2a trial evaluating its investigatio

Sep 8, 2026

Press release

Eligible Successfully Completes SOC 2 Audit with Zero Exceptions

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Eligible, Inc., the healthcare transaction infrastructure company connecting providers, agents, and insurers, today announced the successful completion of its SOC 2 Type II examination for the Platform Services System. All control activities were accepted with zero exceptions across all four Trust Services Categories evaluated — Security, Availability, Processing Integrity, and Confidentiality. The examination, conducted by independent third-party assessor

Minimalist illustration of an RNA molecule and control layer

Sep 8, 2026

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

RNAV8 Bio has secured funding from ARPA-H to advance the PROPEL initiative, aimed at enhancing RNA medicines through programmable control mechanisms.RNAV8 Bio, known for its AI-driven approach to mRNA design, is collaborating with prestigious labs at Harvard and MIT under a $4.4 million ARPA-H pilot program. The PROPEL initiative seeks to leverage RNA’s natural folding behavior to create a tunable control layer for RNA therapeutics. This effort addresses the existing challenges in predicting the

Sep 8, 2026

Press release

Trust AI Just Made Your X-Ray Fight the Insurance Company.

Trust AI wires VELMENI's FDA-cleared dental AI directly into Isaac PracticeOS— turning radiographs your practice already took into documented, reviewed, submitted claims.SAN FRANCISCO, Sept. 8, 2026 /PRNewswire/ -- Trust AI today announced a native integration between VELMENI, the FDA-cleared dental artificial intelligence platform, and Isaac PracticeOS, the AI-native practice management system. The integration brings VELMENI for DENTISTS (V4D) 2D/3D radiographic analysis directly inside Isaac's

Sep 8, 2026

Press release

Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order

A successful multi-site ring trial and early access program demonstrate the reproducibility, scalability, and biological insight of the Metabolon Verus™ Metabolomics Profiling Kit across laboratories worldwideMORRISVILLE, N.C., Sept. 8, 2026 /CNW/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced that the Metabolon Verus™ Metabolomic

Next-generation sequencing machine in a laboratory setting with a sample vial on the bench.

Sep 8, 2026

Clean Cells Broadens Viral Safety Testing Portfolio with NGS

Clean Cells has expanded its viral safety testing capabilities by launching a next-generation sequencing (NGS) service, aimed at enhancing the analysis of viral vectors and recombinant preparations. This initiative is bolstered by the acquisition of Xegen, a bioinformatics CRO specializing in NGS data analysis.The integration of Xegen is intended to fortify Clean Cells' bioinformatics infrastructure, which is crucial for ensuring reliable and auditable data management in NGS workflows. CEO Laure

Sep 8, 2026

Press release

Amino Minder Brings Real Pharmacokinetic Modeling to Peptide and GLP-1 Tracking, Now Live on the Web -- Android App Coming Soon

New tracker goes beyond dose logging to model estimated plasma levels over time, including downstream hormone cascades for GH-secretagogue stacksKINGMAN, Ariz., Sept. 8, 2026 /PRNewswire/ -- Baya Lobo LLC today announced the web launch of Amino Minder (aminominder.com), a peptide, GLP-1, TRT, and HRT protocol tracker built around a feature no competing app currently claims: a real pharmacokinetic (PK) engine that estimates and graphs a user's plasma level for each tracked compound over time, rat

Sep 8, 2026

Press release

Memorial Hermann Health System Clinicians Use Epic's AI Tool to Help Patients Better Understand Test Results

HOUSTON, Sept. 8, 2026 /PRNewswire/ -- Clinicians at Memorial Hermann Health System (MHHS) are using a new artificial intelligence (AI) tool built directly into Epic to help patients better understand their test results and to make informed decisions about next steps in their care journey. Epic's Art is an AI-powered assistant that helps clinicians streamline documentation. As clinicians review lab and imaging results in Epic's In Basket, Art helps generate an initial draft patient note in real

Sep 8, 2026

Press release

LivmorIQ Brings Real Medicare Beneficiary Data to Plan Analysis, The Year-Round Client Retention Platform for Agents and Agencies

Approved for CMS Blue Button API access and named to the CMS Blue Button V3 Advisory Council, Livmor pairs each client's Medicare utilization with the needs they share with their agent, so every senior is aligned with the plan that fits and stays with the agent who found it.PORTLAND, Ore., Sept. 8, 2026 /PRNewswire/ -- Livmor Inc. today announced it has been approved to connect to the Centers for Medicare & Medicaid Services (CMS) Blue Button API and has been named to the CMS Blue Button V3

Back to start
Previous
Page 26 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Legal